Neutralizing anti-influenza binding molecules and uses thereof

US11926657B2 · kind B2 · utility

Assignee

• MedImmune Limited · US

Inventors

• Nicole Kallewaard-Lelay · Gaithersburg, US
• Qing Zhu · Mansfield Center, US
• Godfrey Jonah Anderson Rainey · Gaithersburg, US
• Cuihua Gao · Gaithersburg, US
• Srinath Kasturirangan · Gaithersburg, US
• Changshou Gao · Potomac, US

Key dates

• Filing date: Nov 11, 2022
• Grant date: Mar 12, 2024
• Expiry date: Nov 11, 2042

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/92
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Binding molecules, including bispecific antibodies that include at least two anti-influenza binding domains are disclosed, including binding molecules having a first binding domain that specifically binds influenza A virus and a second binding domain that specifically binds influenza B virus.